Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

XNA-2: a new treatment for skin disorders available for licensing from Xenna

March 30, 1998

Integra Artifical Skin receives CE Mark certification

March 27, 1998

Phase III trials of Microsponge-entrapped 5-FU begin in the U.S.

March 27, 1998

New retinoid-like compounds discovered at Allergan

March 25, 1998

Life Medical Sciences receives FDA approval to begin Repel-CV trials

March 25, 1998

FK-506: a topical agent for the treatment of moderate to severe atopic dermatitis

March 25, 1998

Positive trial results reported for AlloDerm

March 24, 1998

Potential new indication for zafirlukast in the treatment of urticaria

March 23, 1998

PSSO: an alternative to hydrocortisone for the treatment of erythema

March 23, 1998

Schering-Plough and Chugai sign marketing agreement for psoriasis drug

March 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...